Coagulation abnormalities and thrombosis in patients with COVID-19

M Levi, J Thachil, T Iba, JH Levy - The Lancet Haematology, 2020 - thelancet.com
Although most patients with coronavirus disease 2019 (COVID-19) predominantly have a
respiratory tract infection, a proportion of patients progress to a more severe and systemic …

Disseminated intravascular coagulation

M Levi, E de Jonge, T van der Poll… - Thrombosis and …, 1999 - thieme-connect.com
A quick literature search in the MEDLINE databases from 1966 to 1998 using the search term
disseminated intravascular coagulation (DIC) and related key words yields an impressive …

Bidirectional relation between inflammation and coagulation

M Levi, T van der Poll, HR Büller - Circulation, 2004 - Am Heart Assoc
cofactors V and VIII by thrombin, and (3) thrombin-induced factor XI activation, leading to
additional factors IXa and Xa. The assembly of several complexes, such as the “tenase complex,…

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

…, S Gando, A Falanga, M Cattaneo, M Levi… - Journal of Thrombosis …, 2020 - jthjournal.org
The novel corona virus infection (now classified as COVID-19), first identified in December
2019 in Wuhan, China, has contributed to significant mortality in several countries with the …

[HTML][HTML] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

…, F Dentali, F Montecucco, S Massberg, M Levi… - Nature Reviews …, 2021 - nature.com
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease …

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation

…, CH Toh, KW Hoots, H Wada, M Levi - Thrombosis and …, 2001 - thieme-connect.com
4. To establish the importance of continuing to use readily available laboratory tests (eg global
coagulation tests) in diagnostic screening for DIC. It is clear that global coagulation tests …

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

…, MK Sijpkens, JC Meijers, HR Buller, M Levi - Circulation, 2011 - Am Heart Assoc
Background— Rivaroxaban and dabigatran are new oral anticoagulants that specifically
inhibit factor Xa and thrombin, respectively. Clinical studies on the prevention and treatment of …

New fundamentals in hemostasis

HH Versteeg, JWM Heemskerk, M Levi… - Physiological …, 2013 - journals.physiology.org
Hemostasis encompasses the tightly regulated processes of blood clotting, platelet
activation, and vascular repair. After wounding, the hemostatic system engages a plethora of …

Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized …

…, JM Connors, BJ Hunt, T Iba, M Levi… - … of Thrombosis and …, 2020 - Wiley Online Library
Marcel Levi contributed to the concept, interpretation of data, and revision of intellectual
content. Charles Marc Samama contributed to the concept, interpretation of data, and revision of …

Inflammation and coagulation

M Levi - … : From Molecular and Cellular Mechanisms to the Clinic, 2017 - Wiley Online Library
In the majority of patients with systemic inflammatory conditions, some degree of activation
of coagulation is present. Increasing evidence points to an extensive cross‐talk between …